2021
DOI: 10.1016/j.jff.2021.104862
|View full text |Cite
|
Sign up to set email alerts
|

Sodium butyrate inhibits colitis-associated colorectal cancer through preventing the gut microbiota dysbiosis and reducing the expression of NLRP3 and IL-1β

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 71 publications
0
6
0
Order By: Relevance
“…[ 55 ] Moreover, sodium butyrate ameliorated colitis and colitis‐related cancers by attenuating NLRP3 and IL‐1β expression and modulating gut microbiota. [ 56 ] Our findings suggested that SCFAs inhibited the overactivation of NLRP3 inflammasome. Further researches should focus on examining the effect of SCFAs on NLRP3 inflammasome.…”
Section: Discussionmentioning
confidence: 74%
“…[ 55 ] Moreover, sodium butyrate ameliorated colitis and colitis‐related cancers by attenuating NLRP3 and IL‐1β expression and modulating gut microbiota. [ 56 ] Our findings suggested that SCFAs inhibited the overactivation of NLRP3 inflammasome. Further researches should focus on examining the effect of SCFAs on NLRP3 inflammasome.…”
Section: Discussionmentioning
confidence: 74%
“…However, more authors support the fact that NLRP3 inflammasome with its role in inflammation and tumorigenesis will eventually drive the metastases towards the liver. Due to the overexpression of NLRP3, macrophages will drive up the production of proinflammatory interleukines, which through the macrophage activity will promote cell migration [ 79 , 80 ]. Through a bone-marrow-derived macrophage study (BMDM) in human cancer cells (SW480), a significant increase in cell migration was noted.…”
Section: Resultsmentioning
confidence: 99%
“…Blocking NLRP3 signaling is shown to suppress cell migration. Therefore, macrophages can influence the CRC migration through activation of the NLRP3 inflammasomes, increasing IL-1 β secretion which can ulteriorly be decreased by blocking NLRP3 signaling [ 23 , 79 ]. In addition, a study has shown that the expressions of the macrophage surface marker CD-68 and the proinflammatory cytokine IL-1B are positively correlated.…”
Section: Resultsmentioning
confidence: 99%
“…Liu et al. ( 81 ) revealed that NaB could inhibit colorectal carcinoma. The tumor size was significantly reduced in NaB treated mice groups in comparison to the azoxymethane and dextran sulfate sodium salt (AOM/DSS) mice group.…”
Section: Scfas In Oncological Diseasesmentioning
confidence: 99%
“…The average number of tumor was lower in the case of i.p. NaB application ( 81 ). Previous research revealed that oral intake of NaB inhibit DSS-induced colitis in a mouse model, while i.p.…”
Section: Scfas In Oncological Diseasesmentioning
confidence: 99%